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Recent advances have suggested that direct induc-
tion of neural stem cells (NSCs) could provide an
alternative to derivation from somatic tissues or
pluripotent cells. Here we show direct derivation of
stably expandable NSCs from mouse fibroblasts
through a curtailed version of reprogramming to
pluripotency. By constitutively inducing Sox2, Klf4,
and c-Myc while strictly limiting Oct4 activity to the
initial phase of reprogramming, we generated neuro-
sphere-like colonies that could be expanded for
more than 50 passages and do not depend on sus-
tained expression of the reprogramming factors.
These induced neural stem cells (iNSCs) uniformly
display morphological and molecular features of
NSCs, such as the expression of Nestin, Pax6, and
Olig2, and have a genome-wide transcriptional pro-
file similar to that of brain-derived NSCs. Moreover,
iNSCs can differentiate into neurons, astrocytes,
and oligodendrocytes. Our results demonstrate that
functional NSCs can be generated from somatic cells
by factor-driven induction.
INTRODUCTION
Forced expression of lineage-specific factors has been shown
to reprogram the developmental plasticity of various somatic
cell types (Graf and Enver, 2009; Yamanaka and Blau, 2010;
Zhou andMelton, 2008). The seminal report describing induction
of pluripotency in fibroblast cells represented a major break-
through of cellular reprogramming (Takahashi and Yamanaka,
2006). Although substantial progress has been made in terms
of improving the efficiency and robustness of reprogramming,
the derivation of patient-specific iPSCs still is a lengthy and
cumbersome procedure. Moreover, disease-related applica-
tions require subsequent redifferentiation into the desired cell
type, and incomplete differentiation of iPSCs carries the risk of
tumor induction by remaining undifferentiated iPSCs.Recently, factor-driven reprogramming of fibroblasts has been
reported to directly yield other somatic cell types such as
neurons (Caiazzo et al., 2011; Pang et al., 2010; Pfisterer et al.,
2011; Vierbuchen et al., 2010; Yoo et al., 2011), cardiomyocytes
(Efe et al., 2011; Ieda et al., 2010), hepatocyte-like cells (Huang
et al., 2011), blood (Szabo et al., 2010), and neural (Kim et al.,
2011; Lujan et al., 2012) progenitors. These reports demonstrate
that transdifferentiation from one differentiated cell type into
another can be achieved through overexpression of transcription
factors. However, transdifferentiation protocols published thus
far result in somatic cell populations with little or no proliferation
potential. Derivation of somatic stem cells would be highly desir-
able because such cells would be fully expandable and able to
differentiate into multiple lineages in vitro and in vivo. Although
neural stem cells (NSCs) can be derived from either somatic
tissue or pluripotent sources (Conti et al., 2005; Tropepe et al.,
2001; Uchida et al., 2000), the artificial induction of stably
expandable NSCs has remained elusive. Here we show direct
derivation of stably expandable NSCs from fibroblasts through
a curtailed version of reprogramming toward pluripotency. Neu-
rosphere-like colonies were isolated, and the resulting induced
NSC (iNSC) lines maintained their tripotent developmental
potential over prolonged expansion (>50 passages) and were
not dependent on sustained expression of reprogramming
factors.RESULTS
Derivation of Neurosphere-like Clusters by Curtailed
Reprogramming
Self-renewing NSCs can be derived from ESCs and fetal or
adult forebrain (Uchida et al., 2000; Tropepe et al., 2001; Conti
et al., 2005; Pollard et al., 2006). Such NSCs display many
hallmarks of radial glia by morphology and molecular markers
and are able to differentiate into neurons, astrocytes and
oligodendrocytes. Because NSCs endogenously express a
subset of iPSC reprogramming factors, namely Sox2, Klf4, and
c-Myc, but not Oct4, we investigated whether curtailed reprog-
ramming with restricted Oct4 activity could convert fibroblasts
into NSCs. To test our hypothesis we infected mouse embryonic
fibroblasts (MEFs) with retroviruses constitutively expressingCell Stem Cell 10, 473–479, April 6, 2012 ª2012 Elsevier Inc. 473
Figure 1. Generation and Characterization of iNSCs from Mouse Embryonic Fibroblasts
(A) Schematic drawing of the experimental setup and strategy to derive induced neural stem cells (iNSCs).
(B) Neurosphere-like colony at day 25 with axonal structures processing out of the sphere.
(C) Neurosphere-like colony at day 27 stained with a specific antibody directed against the neuronal marker b-III-tubulin.
(D) Neurosphere-like colony isolated by manual picking, grown on a POL-coated culture dish. iNSCs are migrating out of the sphere (defined as passage 0).
(E) iNSCs (passage 1) were dissociated to a single-cell suspension, seeded onto a POL-coated culture dish, and cultured for 2 days.
(F–I) Immunofluorescence analysis of NSC marker proteins in iNSCs using specific antibodies directed to Nestin and Olig2 (G), Sox2 and BLBP (H), and
mesenchymal marker Vimentin (I). A phase contrast micrograph is shown in (F).
(J and K) Phase contrast pictures of iNSCs in NS propagation medium at passage 5 (J) and 31 (K).
(L and M) iNSCs at passage 12 (L) and passage 31 (M) were stained for NSC markers Nestin and Pax6.
(N and O) iNSCs form secondary neurospheres when kept in suspension culture (N). After plating on POL-coated culture dishes, spheres get adherent and
iNSCs migrate out (O).
(P) Mean doubling time (mdt) and growth curve of three iNSC lines (clone 3-5) in comparison to brain-derived NSCs (NS). sd, standard derivation. n = 6.
Scale Bars: 50 mm. See also Figure S1.
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Derivation of Expandable Tripotent iNSCsSox2, Klf4, and c-Myc (SKC) (Figure 1A). To achieve control of
Oct4 activity, we used a lentivirus enabling doxycyline (DOX)-
controlled Oct4 activation (Soldner et al., 2009). We used media
with reduced fetal calf serum (FCS, 2%) for transdifferentiation of
fibroblast cells into NSCs because, although FCS is required for
efficient propagation of fibroblasts, it induces unwanted terminal
differentiation of NSCs. We compensated for the reduced serum
content by applying serum replacement, which exhibits marginal
effects only on NSC differentiation (data not shown). Approxi-
mately 130,000 Oct4-GiP (GFP-IRES-puro) reporter MEF cells474 Cell Stem Cell 10, 473–479, April 6, 2012 ª2012 Elsevier Inc.(Ying et al., 2002) were transduced and kept in the presence of
DOX for up to 5 days to ensure expression of Oct4 temporarily
and yet maintain the expression of the other three factors.
Rare neurosphere-like colonies emerged that exhibited neither
iPSC-like morphology nor GFP fluorescence by 11 days postin-
fection (p.i.). Cultures that had been treated with DOX for 5 days
also yielded GFP-positive iPSC-like colonies. From this observa-
tion we concluded that a short and strictly regulated pulse of
Oct4 expression is critical for NSC induction, but prolonged
expression of Oct4 favors iPSC induction. Moreover, we
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Derivation of Expandable Tripotent iNSCsreasoned that the basal activity of the DOX system in the
absence of the inducer does not allow a tightly regulated abroga-
tion of Oct4 activation that is sufficient to impede terminal iPSC
formation. Thus, we employed systems that enablemore precise
control over Oct4 activity and involve direct delivery of cell-
permeant Oct4 protein (Bosnali and Edenhofer, 2008; Thier
et al., 2010; Zhou et al., 2009) and mRNA (Warren et al., 2010),
respectively. Five days of Oct4 protein transduction into
130,000 SKC-infected fibroblasts generated up to 11 GFP-
negative neurosphere-like structures (Figure 1B). Staining of
neurosphere-like colonies at the primary plate revealed b-III-
tubulin-positive processes emanating from the colonies (Fig-
ure 1C). Similar structures were found in SKC-infected tail tip
fibroblast cells transfected with Oct4-encoding mRNA (Fig-
ure S1 available online). The colonies were picked 18 days p.i.
and plated in NS propagation medium. NSC-like cells grew out
of the spheres (Figure 1D) and could be kept in adherent culture
(Figure 1E).
Artificially Induced iNSCs Are Similar to Brain-Derived
NSCs
To investigate the identity of the induced NSCs (iNSCs), we
performed comprehensive molecular characterization at the
protein and mRNA level. Immunostaining revealed that the
transdifferentiated cells consistently expressed numerous NSC
markers including Nestin and Olig2 (Figures 1F and 1G), Sox2,
and Blbp (Figure 1H). RT-PCR analyses of transdifferentiated
cells confirmed transcription ofPax6,Blbp, andSox2 (Figure S1),
all of which are characteristic markers of NSCs (Conti et al.,
2005). Next we assessed the capability of iNSCs to self renew
and grow clonally under proliferation conditions. We reproduced
the derivation of iNSCs in three independent experiments, each
employing 130,000 cells and yielding between 7 and 11 neuro-
sphere-like structures. In total, we isolated five of these struc-
tures, and four of them could be stably expanded. All four iNS
lines analyzed expressed NSC markers and were expandable
for more than 50 passages without changes in their morphology
and growth properties (Figures 1J–1O). Themean doubling times
of iNSCs were found to be similar to that of brain-derived control
NSCs (Figure 1P). The characteristic profile of NSC marker
expression did not change after prolonged passaging as judged
by staining for Pax6 and Nestin (Figures 1L and 1M). To assess
the secondary neurosphere-forming potential of iNSCs, we
generated single-cell suspensions that were cultured in
uncoated flasks forming secondary neurospheres (Figure 1N)
that were able to grow again in adherent culture (Figure 1O).
Using this approach, more than 60% of the spheres could be
expanded. In conclusion, fibroblast-derived transdifferentiated
cells represent a homogenous proliferating cell population
resembling a previously described radial glia NSC type (Conti
et al., 2005).
Genome-Wide Transcriptional Profiling of iNSCs
and Transgene Silencing
To analyze the similarities between iNSCs and control NSCs,
we generated comparative global gene expression data by
microarray analysis. Scatter plots of the scores for MEFs and
ESCs, respectively, versus iNSC-2 cells (Figures 2A and 2B) re-
vealed a significant difference between iNSCs and their parentalMEFs and pluripotent cells. In contrast, iNSC-2 cells are very
similar to the control NSC line (Figure 2C) and the sister clone
iNSC-5 isolated from the same transdifferentiation experiment
(Figure 2D). Hierarchical cluster analysis revealed a high degree
of similarity between all NSC lines independent of their origin
(Figure 2E). Although there are subtle differences in the global
gene expression profiles of the three iNSC lines tested, all
of them are clearly distinct from both MEFs and ESCs. One of
the established iNSC lines (iNSC-2) is particularly similar to
the NSC control line derived from fetal brain (Figures 2C, 2E,
and 2F). Numerous genes known to be involved in NSC self-
renewal or neural determination, such as Foxg1, Nes, Bmi1,
and Olig2, are strongly upregulated in iNSCs and NSCs
compared toMEF cells (Figure 2F). Transcription of several fibro-
blast-specific genes such as Col1a1, Col3a1, Dkk3, and Thy1 is
downregulated (Figure 2F), but there is also a subset of genes
exhibiting similar expression in MEFs and iNSCs (Figure S2A),
suggesting some residual fibroblast epigenetic memory. To
examine whether iNSCs exhibit a regional identity, we selected
region-specific transcription factors from the microarray data
set and assessed them via RT-PCR analysis. Although both
iNSC and NSC controls share high expression of some forebrain
markers such as Emx2, Foxg1, and Nr2e1, they exhibit low
expression of forebrain-specific Emx1 (Figures S2B and S2C).
Some mid/hindbrain-specific mRNAs including Gbx2 and Egr2
are highly abundant in contrast to Pax2, which exhibits low
transcript levels. We found ventral markers Olig2 and Nkx2.2
highly expressed and low expression of dorsal markers Pax3
and Pax7. In conclusion, like their counterparts derived from
brain, iNSCs do not fully correlate with a specific regional
identity but are mostly compatible with a ventral fore/mid/hind-
brain fate.
Retroviral iPSC generation involves gradual silencing of re-
programming transgenes during the induction of pluripotency.
In fact, transgene silencing is a prerequisite for normal differen-
tiation of iPSCs (Brambrink et al., 2008). Recent publications
suggest that the stability of transdifferentiated phenotypes, in
contrast, appear to depend on the sustained overexpression of
reprogramming transgenes (Ieda et al., 2010; Sheng et al.,
2011). We thus asked whether the self-renewal capacity and
cellular identity of iNSCs depends on sustained overexpression
of the exogenous reprogramming transgenes. RT-PCR analyses
revealed that none of the four iNSC lines analyzed expressed
transgenic Sox2, Klf4, or c-Myc. However, all of the lines
exhibited induction of endogenous Sox2 expression and no
expression of endogenous Oct4 (Figure 2G). To verify the initial
requirement for the transdifferentiation factors, we performed
genomic PCR analyses and found that the four iNSC lines
analyzed carry genomic integrations of all three reprogramming
transgenes (Figure 2H).
iNSCs Differentiate into Neurons, Astrocytes,
and Oligodendrocytes
Next we set out to examine the developmental potential of
iNSCs by assessing their capacity for differentiation into the
three main neural lineages. Astrocytic differentiation of iNSCs
was induced by exposure to FCS, yielding cells with astrocyte
morphology that uniformly stain for glial fibrillary acidic protein
(GFAP) (Figure 3A). To target differentiation of iNSCs towardCell Stem Cell 10, 473–479, April 6, 2012 ª2012 Elsevier Inc. 475
Figure 2. Genome-Wide Transcriptional Profiling of iNSCs and Analysis of Transgene Silencing
(A–D) Homogeneity of gene expression visualized by scatter plot presentation. Shown are plots of the averaged intensities of each group against the induced
NSC clone 2 (iNSC2). Detection p values are% 0.01.
(E and F) Hierarchical cluster analysis and heatmap presentation of microarray expression analysis of MEF cells, three iNSC lines (iNSC2, 3, 5), NS control cells
(NSC), and ESCs (ESC). All samples had been processed in at least triplicate to reduce signals arising from processing artifacts. Plotted are the differential score
values of 147 genes selected by text-mining for the term ‘‘neuro’’ in the gene definition data provided by GenomeStudio (E) and a subset of selected neural,
pluripotency, and fibroblast-specific genes (F) as computed by GenomeStudio’s differential gene analysis algorithm.
(G) RT-PCR analyses of four iNSC lines (clone 2-5) for sustained expression of the retroviral transgenes as well as endogenous expression of Oct4, Sox2, and
Nanog. RNA preparations of uninfected MEFs, SKC-infected MEFs (SKC), and ESCs as well as a brain-derived NSC line serve as controls. All four iNSC lines
analyzed exhibit expression of endogenous Sox2 like the NSC sample. Transcription of transgenic factors was not observed. Primer pair detecting the glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH) is used as loading control.
(H) Genomic PCR to verify integration of retroviral constructs used for partial reprogramming. Primer pair detecting endogenous b-actin serve as loading control.
See also Figure S2.
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Derivation of Expandable Tripotent iNSCsthe oligodendroglial fate, we used a protocol employing media
containing forskolin, triiodothyronine, and ascorbic acid.
Staining revealed oligodendrocyte marker O4-positive cells
with characteristic morphology (Figure 3B). For neuronal differ-
entiation iNSCs were cultivated in the absence of EGF/FGF but
in the presence of BDNF. Differentiated cells showed neuronal
morphology and expression of the neuronal markers b-III-tubulin
(Figure 3C) andNeuN (Figures 3D and 3E) aswell asmicrotubule-
associated protein (MAP2) (Figures 3C and 3F). Quantification of
the differentiated cells demonstrated that the differentiation
potential of iNSCs is high for astrocytes and neurons whereas
oligodendroglial differentiation is relatively rare (Figure 3G).
Thus, iNSCs are very similar to their counterparts derived from
brain tissue for which oligodendrocyte differentiation is chal-
lenging (Figure S3A) (Conti et al., 2005; Glaser et al., 2007).476 Cell Stem Cell 10, 473–479, April 6, 2012 ª2012 Elsevier Inc.Nevertheless, the differentiation spectrum of iNSCs is not
restricted to neurons and astrocytes but extends also to oligo-
dendrocytes. All four iNSC lines analyzed exhibit a similar
potential to differentiate into neurons (Figure S3B). Further
cellular characterization of iNSC-derived neurons revealed that
the majority developed a GABAergic phenotype (Figure 3H)
and some are able to express synaptic proteins (Figure 3I). To
analyze whether the resulting neurons exhibit functional
membrane properties, we performed whole-cell patch-clamp
recordings after 3 weeks of differentiation. This analysis revealed
the expression of a complex outward current pattern including
inactivating and sustained components (Figure 3J). This pattern
is reminiscent of neurons expressing both A-type and delayed
rectifier potassium channels. In contrast to these high-amplitude
outward currents, transient inward currents were only of small
Figure 3. In Vitro Differentiation Potential of iNSCs
(A–C) iNSCs differentiate into astrocytes, oligodendro-
cytes, and neurons in vitro as judged by immunofluores-
cence analyses using specific antibodies directed against
GFAP, O4, b-III-tubulin, and MAP2ab.
(D and E) iNSC-derived neurons stain positive for the
neuron-specific marker NeuN. (E) shows a magnification
of (D).
(F and H) iNSC-derived neurons expressing the mature
neuronal marker MAP2ab and GABA, respectively.
(G) Quantification of the differentiation potential of iNSCs
into neurons, astrocytes, and oligodendrocytes. About
30% of the iNSC-derived progeny stain TUJ1-positive
when cultured in N2 medium without EGF and bFGF. In
serum-containing medium, almost 100% of the cells
differentiate into astrocytes. About 3% oligodendrocytes
are found after culture in N2 medium with PDGF, For-
skolin, and T3 followed by N2 medium with ascorbic acid.
(I) Staining of iNSC-derived neurons for Synapsin and b-III-
tubulin after three weeks of differentiation.
(J–M) Physiological properties of iNSC-derived neurons
assessed by whole-cell patch-clamp recordings. (J)
Complex outward current pattern including inactivating
and sustained components reminiscent of neurons ex-
pressing both A-type and delayed rectifier potassium
channels. (K) Current-clamp experiment of an iNSC-
derived neuron able to fire an action potential, thus
demonstrating membrane excitability. (L and M) Local
application of either 15 mM L-glutamate (L) or 15 mM
GABA (M) elicited a clear current response, indicating
the expression of functional neurotransmitter receptors
(n = 5 and 3, respectively). Stainings were performed
after 2 weeks of differentiation if not otherwise stated.
Recordings were done after 3 weeks.
Scale bars: 50 mm. See also Figure S3.
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Derivation of Expandable Tripotent iNSCsamplitude. However, in current-clamp experiments some cells
(five of seven) were able to fire an action potential, demonstrating
membrane excitability (Figure 3K). Furthermore, the neurons
displayed surface expression of glutamate and GABAA recep-
tors (n = 5 and n = 3, respectively, Figures 3L and 3M), which
is a prerequisite for the formation of glutamatergic and
GABAergic synapses.
Finally, we conducted first studies to assess the in vivo
developmental potential of iNSCs. Specifically, we wanted to
explore whether iNSCs might be suitable for glial cell replace-
ment. To address this question, we transplanted them into
the brain of neonatal myelin-deficient (md) rats. Cells were
transplanted into the left and right hemispheres and 2 weeks
later detected by staining against the murine neural marker
M2 and oligodendroglial proteolipid protein (PLP), which is
deficient in the md rat brain. These in vivo studies revealed
iNSC-derived M2-positive cells with astrocyte morphology in
a variety of host brain regions including cortex and striatum
(Figure 4). Many of the M2-positive profiles could be double-
labeled with an antibody to GFAP (Figures 4B and 4C). In
addition, PLP-positive profiles were detected in white matter
structures such as the corpus callosum (Figure 4D). While theseCell Stem Cell 1data need to be complemented by other glial
markers and an assessment of in vivo neuronal
differentiation, they clearly demonstrate thatgrafted iNSCs survive and give rise to differentiated neural
cells in vivo.
DISCUSSION
Our data demonstrate the induction of stably expandable
iNSCs from fibroblasts using a curtailed version of repro-
gramming toward pluripotency. iNSCs uniformly exhibit
morphological and molecular features of NSCs such as the
expression of Nestin, Olig2, Sox2, Blbp, and Pax6. Genome-
wide transcriptional profiling confirms a high degree of
similarity between artificially induced NSCs and their counter-
parts derived from mouse brain. Moreover, we demonstrate
tripotential differentiation capacity of iNSCs into the three
main neural lineages. Notably, iNSCs are able to generate
primary and secondary neurospheres and maintain their marker
expression profile and differentiation capacity over prolonged
expansion (>50 passages). The uniformity and stability of
growth characteristics and marker expression together with
long-term maintenance of tripotential neural differentiation
capability suggest that iNSCs represent a stably proliferating
somatic stem cell type. Thus, in conclusion, iNSCs show0, 473–479, April 6, 2012 ª2012 Elsevier Inc. 477
Figure 4. Transplantation of iNSCs into the Brains of Neonatal Rats
iNSCs were transplanted into the left and right hemispheres of postnatal
myelin-deficient rats. Two weeks after transplantation rats were sacrificed and
brain slices were analyzed.
(A) M2 antibody marks murine iNSC-derived mouse cells integrated into the
rat brain.
(B–D) Immunofluorescence analyses using specific antibodies targeted
against astrocyte-specific GFAP (B and C), neuron-specific NeuN (C), and
oligodendrocyte-specific PLP (D). M2/GFAP double-positive mouse astro-
cytes are found in close contact with a blood vessel. Thewhite x in (B) indicates
the lumen of the vessel. Arrowheads in (C) point to iNSC-derived M2/GFAP
double-positive astrocyte processes that surround host neurons.
Scale bars: 50 mm.
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multipotentiality.
Recent studies have shown that direct conversion of fibro-
blasts into other somatic cell types including neurons (Caiazzo
et al., 2011; Pang et al., 2010; Pfisterer et al., 2011; Vierbuchen
et al., 2010; Yoo et al., 2011) and neural progenitors (Kim et al.,
2011; Lujan et al., 2012) is feasible. Kim et al. recently reported
the direct reprogramming of fibroblasts to neural progenitor cells
(NPCs) by employing DOX-controlled overexpression of Oct4,
Sox2, Klf4, and c-Myc. The authors demonstrate that differ-
entiation of such transdifferentiated NPCs yields neurons and
astrocytes. The oligodendrocyte differentiation capability re-
mained unclear, however. Moreover, the NPCs were reported
to lose their ability to form colonies within three to five passages
(Kim et al., 2011). Our data demonstrate that iNSCs, by contrast,
are stably expandable (thus far for more than 50 passages) and
exhibit tripotential neural differentiation. We deliberately used
a regulated system for Oct4 while constitutively inducing activity
of the other three factors (Sox2, Klf4, and c-Myc) that are
expressed endogenously in NSCs. We reasoned that this
approach could combine strong neuroinductive capacity from
high levels of Sox2, Klf4, and c-Myc, but reduced induction of
pluripotency through limiting the expression of Oct4. In this
regard, Oct4 protein transduction or mRNA transfection may
be preferable to transcriptional control due to the leakage of
basal Oct4 expression in the absence of inducer. Temporary
use of cell-permeant Oct4 protein allows precise and unambig-
uous cessation of Oct4 reprogramming activity.478 Cell Stem Cell 10, 473–479, April 6, 2012 ª2012 Elsevier Inc.The transcriptional activityof viral transgenes in reprogrammed
cells represents a critical issue. While conventional iPSC genera-
tion requires transgene silencing, recently published transdiffer-
entiation studies report incomplete silencing of reprogramming
genes, indicating that sustained expression of exogenous
genes is necessary for the maintenance of the reprogrammed
phenotype (Ieda et al., 2010; Sheng et al., 2011). Employing the
transdifferentiation paradigm described in this study, we demon-
strate that the three transgenes needed (Klf4, c-Myc, Sox2) are
silenced in all derived iNSC lines analyzed. Concomitantly, we
show that endogenous Sox2 is upregulated in iNSCs. In conclu-
sion, we show that self-renewal of iNSCs does not depend on
sustained transgene expression, but seems to be triggered by
activation of the intrinsic NSC transcriptional program as indi-
cated by the switch from exogenous overexpression of Sox2 to
efficient expression of endogenous Sox2. Additionally, this
finding suggests that it may be possible to use entirely trans-
gene-free approaches to derive iNSCs by delivering Klf4, c-
Myc, and Sox2 using mRNA or proteins. Future studies remain
to be done to adapt this iNSC protocol to human cells and to
eventually substitute viral Sox2,Klf4, andc-Mycwithnonintegrat-
ing delivery modes or small molecules. We anticipate that iNSCs
could provide a safe and robust cellular platform for the genera-
tion of patient-specific neural cells for biomedical applications.
EXPERIMENTAL PROCEDURES
Cell Culture and Infection
Oct4-GiP MEFs (Ying et al., 2002) were infected with retroviruses encoding for
Sox2, Klf4, and c-Myc. For tet-controlled experiments, MEFs were infected
with lentiviruses FUW-Oct4 and M2rtTA (Soldner et al., 2009), which was
followed by a second infection with retroviruses encoding for Sox2, Klf4,
and c-Myc (Takahashi and Yamanaka, 2006). Oct4-TAT protein (Bosnali and
Edenhofer, 2008) and 2 mg/ml DOX (Sigma, Saint Louis, MO) were applied after
the virus-containing supernatant had been removed. Experiments were
carried out in iNSC induction medium (DMEM/F12, 2% FCS, 8% Serum
Replacement, 1x N2, 2 mM L-glutamine, 100 mM b-mercaptoethanol, 1x
NEAA and 1000 U/ml ESGRO; all media and cell culture supplements were
purchased from Life technologies, Carlsbad, CA, if not otherwise stated). After
18–22 days neurosphere-like colonies were picked, transferred to Polyorni-
thine/Laminin (POL)-coated culture dishes, and kept in NS propagation
medium (Euromed-N, EuroClone, Siziano, Italy), 1x N2, 10 ng/ml bFGF, and
10 ng/ml EGF (R&D Systems, Minneapolis, MN). iNSCs were characterized
by RT-PCR analyses, immunofluorescence staining, and microarray analyses
as given in the Supplemental Information.
iNSC Differentiation
For the generation of astrocytes, iNSCs were kept in 10% FCS-containing
medium supplemented with 1x NEAA and 2 mM L-glutamine. For neuronal
differentiation iNSCs were plated onto POL-coated dishes and kept in a 1:1
mix of Neurobasal Medium and DMEM/F12 supplemented with N2, B27,
and 10 ng/ml BDNF, as well as 200 mM ascorbic acid (Sigma, Saint Louis,
MO). Half of the medium was replaced every other day. After 2 weeks of
culture, the ratio was changed to 3:1 and N2 supplement was reduced to
0.5%, while BDNF was increased to 20 ng/ml. To derive oligodendrocytes,
iNSCs were cultivated in DMEM/F12 with 1x N2, 10 ng/ml PDGF (R&D
Systems, Minneapolis, MN), and 10 mM forskolin (Sigma, Saint Louis, MO)
for 4 days. Afterwards, PDGF and forskolin were replaced by 30 ng/ml 3,3,5-
triiodothyronine (T3) hormone and 200 mM ascorbic acid (all from Sigma, Saint
Louis, MO) for another 7 days.
Analysis of Transplanted iNSCs
Cells were transplanted into postnatal md rats (kind gift of Ian Duncan) as
described previously (Glaser et al., 2007). Brain slices were incubated with
Cell Stem Cell
Derivation of Expandable Tripotent iNSCsprimary antibodies targeted against PLP (rb; 1:100, Abcam, Cambridge, UK),
M2 (rat; 1:250, Developmental Studies Hybridoma Bank, Iowa City, IO),
NeuN (ms; 1:50, Millipore, Billerica, MA), and GFAP (rb; 1:1,000; DAKO,
Hamburg, Germany) overnight at room temperature. Alexa 488-, Cy3-, and
Cy5-conjugated secondary antibodies were used (4 hr at room temperature)
for visualization. Pictures were taken using a Zeiss Apotome microscope
and an AxioVision camera (Carl Zeiss, Jena, Germany).
ACCESSION NUMBERS
The accession number for the microarray data reported here is GSE36484.
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes three figures, one table
and Supplemental Experimental Procedures and can be found with this article
online at doi:10.1016/j.stem.2012.03.003.
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